| トルコ | オーストリア | スペイン | |
| 卵巣がんの放射線治療 | から $5,500 | - | から $4,086 |
Bookimedは卵巣がんの放射線治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。到着時にクリニックで卵巣がんの放射線治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。卵巣がんの放射線治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。卵巣がんの放射線治療の旅路でお一人になることはありません。
ハジェテペ大学がん研究所およびMDアンダーソンがんセンターで研鑽を積み、放射線療法による卵巣がん治療を専門とする。
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.
Dr. Mehmet Doğu Canoğlu is a radiation oncologist. He graduated from Kocaeli University Faculty of Medicine. He completed his residency in radiation oncology at Kocaeli University from 2006 to 2012.
He completed his compulsory service at Diyarbakır Training and Research Hospital. He then worked at Bağcılar Training and Research Hospital and at Medipol Mega University Hospital from 2015 to 2017. Since 2017, he has been a radiation oncologist at Anadolu Medical Center.
Ovarian cancer survival in Turkey aligns with global standards, showing a 50% 5-year relative survival rate. While radiation therapy is rarely a first-line treatment, Turkish oncology centers achieve up to 90% local tumor control using advanced technologies like TrueBeam STx and MR LINAC for localized recurrences or palliative care.
Bookimed Expert Insight: Data suggests a shift toward MR LINAC-guided therapy for complex cases, especially at centers affiliated with US institutions like Johns Hopkins. While standard radiotherapy costs around $6,000, these high-precision `smart` radiation packages at Anadolu Medical Center range from $14,500 to $15,000. This investment often eliminates the need for hospital stays, as these systems adapt to daily anatomical changes, potentially reducing side effects compared to traditional techniques.
Patient Consensus: Patients emphasize that while radiation is rarely the primary treatment, it serves as a vital tool for managing isolated recurrences. Many survivors highlight the importance of preparing for gastrointestinal fatigue and suggest that palliative radiation effectively extended their symptom-free periods by up to 18 months.
Patients typically experience fatigue, bowel irritation, and bladder urgency beginning 2 to 3 weeks into pelvic radiation. These acute effects result from inflammation in the treatment area. Most symptoms resolve within a few months, though long-term changes like vaginal stenosis or early menopause may occur.
Bookimed Expert Insight: Advanced technologies like MR LINAC-guided therapy available at Anadolu Medical Center allow for real-time adjustments. This precision targeting significantly reduces radiation exposure to the healthy bowel and bladder. Choosing clinics using EDGE LINAC or TrueBeam STx often results in milder acute side effects compared to traditional radiation methods.
Patient Consensus: Expect symptoms like urinary burning to feel like a constant UTI. Many patients recommend arranging help for daily errands during the peak fatigue period in the second month of treatment.
Turkey is a premier destination for advanced radiation therapy due to its combination of JCI-accredited facilities, internationally trained oncologists, and cutting-edge technology. Centers utilize high-precision systems like MR-Linac and CyberKnife M6 to target tumors while preserving healthy tissue, matching Western clinical standards with significantly shorter wait times.
Bookimed Expert Insight: Data shows Turkey's leading oncology centers, like Anadolu Medical Center, maintain a strategic advantage through direct affiliations with Johns Hopkins Medicine. Beyond just lower costs, this partnership ensures patients receive identical treatment protocols to top US hospitals. When selecting a package, look for those including EDGE LINAC technology, which allows for faster sessions and fewer side effects compared to standard radiotherapy.
Patient Consensus: Patients frequently highlight the logistical ease of receiving therapy in Istanbul, noting that English-speaking staff and VIP transfers reduce the stress of a 20-30 session treatment course.
Turkey hosts several JCI-accredited institutions recognized for advanced ovarian cancer radiotherapy. Leading centers like Anadolu Medical Center and Memorial Şişli Hospital utilize precise technologies including MR-Linac and TrueBeam STx. These facilities maintain global standards through affiliations with Johns Hopkins Medicine and expert radiation oncologists.
Bookimed Expert Insight: Anadolu Medical Center stands out because its specialists, like Dr. Banu Atalar, often hold Stanford fellowships. This deep academic connection allows them to offer MR LINAC-guided adaptive therapy. This specific technology is rare even in Europe and simplifies treatment by potentially removing the need for hospital stays.
Patient Consensus: Patients often highlight that radiation is rarely a standalone treatment in Turkey. They emphasize the importance of choosing centers like Acibadem or Memorial that integrate targeted radiotherapy with advanced chemotherapy protocols.